Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Investigation of Chlamydia pneumoniae infection in Moroccan patients suffering from cardiovascular diseases.

Yazouli LE, Hejaji H, Elmdaghri N, Alami AA, Dakka N, Radouani F.

J Infect Public Health. 2018 Mar - Apr;11(2):246-249. doi: 10.1016/j.jiph.2017.07.029. Epub 2017 Aug 30.

2.

Molecular characterisation of Chlamydia pneumoniae associated to atherosclerosis.

El Yazouli L, Criscuolo A, Hejaji H, Bouazza M, Elmdaghri N, Aroussi Alami A, Amraoui A, Dakka N, Radouani F.

Pathog Dis. 2017 Jun 1;75(4). doi: 10.1093/femspd/ftx039.

PMID:
28387800
3.

Comparison of the Protective Effects of Individual Components of Particulated trans-Sialidase (PTCTS), PTC and TS, against High Cholesterol Diet-Induced Atherosclerosis in Rabbits.

Garavelo SM, Higuchi ML, Pereira JJ, Reis MM, Kawakami JT, Ikegami RN, Palomino SA, Wadt NS, Agouni A.

Biomed Res Int. 2017;2017:7212985. doi: 10.1155/2017/7212985. Epub 2017 Feb 27.

4.

Association between infectious burden, socioeconomic status, and ischemic stroke.

Palm F, Pussinen PJ, Aigner A, Becher H, Buggle F, Bauer MF, Grond-Ginsbach C, Safer A, Urbanek C, Grau AJ.

Atherosclerosis. 2016 Nov;254:117-123. doi: 10.1016/j.atherosclerosis.2016.10.008. Epub 2016 Oct 5.

PMID:
27728851
5.

A 5-Year Retrospective Review of Avian Diseases Diagnosed at the Department of Pathology, University of Georgia.

Nemeth NM, Gonzalez-Astudillo V, Oesterle PT, Howerth EW.

J Comp Pathol. 2016 Aug-Oct;155(2-3):105-120. doi: 10.1016/j.jcpa.2016.05.006. Epub 2016 Jun 18.

PMID:
27329003
6.

Correlation of bacterial coinfection versus matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 expression in aortic aneurysm and atherosclerosis.

Roggério A, Sambiase NV, Palomino SA, de Castro MA, da Silva ES, Stolf NG, de Lourdes Higuchi M.

Ann Vasc Surg. 2013 Oct;27(7):964-71. doi: 10.1016/j.avsg.2013.02.012.

PMID:
23993112
7.

Differential identification of atypical pneumonia pathogens in aorta and internal mammary artery related to ankle brachial index and walking distance.

Iriz E, Cirak MY, Zor MH, Engin D, Oktar L, Unal Y.

J Surg Res. 2013 Aug;183(2):537-41. doi: 10.1016/j.jss.2013.01.053. Epub 2013 Feb 15.

PMID:
23535111
8.

Persistently elevated IgA antibodies to Mycoplasma pneumoniae in patients with internal carotid artery stenosis.

Daxböck F, Assadian A, Watkins-Riedel T, Assadian O.

GMS Krankenhhyg Interdiszip. 2011;6(1):Doc04. doi: 10.3205/dgkh000161. Epub 2011 Dec 15.

9.

Antibodies to common infectious agents in coronary artery disease patients with and without rheumatic conditions.

Grub C, Brunborg C, Hasseltvedt V, Aukrust P, Førre O, Almdahl SM, Hollan I.

Rheumatology (Oxford). 2012 Apr;51(4):679-85. doi: 10.1093/rheumatology/ker251. Epub 2011 Dec 11.

PMID:
22157685
11.

Infectious atherosclerosis: is the hypothesis still alive? A clinically based approach to the dilemma.

Alviar CL, Echeverri JG, Jaramillo NI, Figueroa CJ, Cordova JP, Korniyenko A, Suh J, Paniz-Mondolfi A.

Med Hypotheses. 2011 Apr;76(4):517-21. doi: 10.1016/j.mehy.2010.12.006. Epub 2011 Jan 8.

PMID:
21216537
12.

The association between mycoplasma infections and atherosclerosis: myth or clinical reality?

Nussinovitch U.

Isr Med Assoc J. 2010 Jul;12(7):439-40. No abstract available.

13.

Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.

Damy SB, Higuchi ML, Timenetsky J, Reis MM, Palomino SP, Ikegami RN, Santos FP, Osaka JT, Figueiredo LP.

BMC Microbiol. 2009 Sep 10;9:194. doi: 10.1186/1471-2180-9-194.

14.

Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae in different forms of coronary disease.

Maia IL, Nicolau JC, Machado MN, Maia LN, Takakura IT, Rocha PR, Cordeiro JA, Ramires JA.

Arq Bras Cardiol. 2009 Jun;92(6):405-11, 422-8, 439-45. English, Multiple languages.

15.

Detection of infectious agents by polymerase chain reaction in human aortic wall.

Reszka E, Jegier B, Wasowicz W, Lelonek M, Banach M, Jaszewski R.

Cardiovasc Pathol. 2008 Sep-Oct;17(5):297-302. doi: 10.1016/j.carpath.2007.11.002. Epub 2008 Feb 5.

PMID:
18402822
16.

Effects of atypical pneumonia agents on progression of atherosclerosis and acute coronary syndrome.

Iriz E, Cirak MY, Engin ED, Zor MH, Erer D, Imren Y, Turet S, Halit V.

Acta Cardiol. 2007 Dec;62(6):593-8.

PMID:
18214125
17.

Morphometrical quantification of Chlamydia pneumoniae and Mycoplasma pneumoniae in human atherosclerotic abdominal aortic aneurysms.

Pires LJ, Gutierrez PS.

Rev Bras Cir Cardiovasc. 2007 Jul-Sep;22(3):322-31. English, Portuguese.

PMID:
18157418
18.

Association of common chronic infections with coronary artery disease in patients without any conventional risk factors.

Goyal P, Kalek SC, Chaudhry R, Chauhan S, Shah N.

Indian J Med Res. 2007 Feb;125(2):129-36.

PMID:
17431281
19.

Infectious agents, inflammation, and growth factors: how do they interact in the progression or stabilization of mild human atherosclerotic lesions?

Góis J, Higuchi M, Reis M, Diament J, Sousa J, Ramires J, Oliveira S.

Ann Vasc Surg. 2006 Sep;20(5):638-45. Epub 2006 Sep 17.

PMID:
16983590
20.

A microbial TLR2 agonist imparts macrophage-activating ability to apolipoprotein A-1.

Hasebe A, Pennock ND, Mu HH, Chan FV, Taylor ML, Cole BC.

J Immunol. 2006 Oct 1;177(7):4826-32.

Supplemental Content

Loading ...
Support Center